Bradyarrythmia induced by repeated dose of succinylcholine
To the Editor: We read with interest the article by Nigrovic ~ concerning his hypothesis on the mechanism of adverse haemodynamic reactions to suceinylcholine. When Nigrovic discusses bradyarrythmia following a repeated dose of succinylcholine, he points out the study of Mathias et al. 2 who concluded that pre-curarisation with a non-depolarizing drug such as d-tubocurarine can prevent this phenomenon, an opinion usually accepted by the anaesthetist. 3 We would like to emphasize that this preventi.on of bradyarrythmia is not the case. We recently did a double blind study which included 24 women, ASA physical status I, in which we examined the efficacy of diazepam in preventing bradyarrythmias induced by a second dose of succinylcholine (1 mg'kg-I). The patients were randomly divided into three groups of eight patients each according to the pre-treatments received: G-I, intravenous diazepam (0.05mg'kg-t), G-II, d-tubocurarine (0.06 mg.kg -~) and G-Ill, placebo (NaCI 0.9 per cent). Four cases of sinus arrest (3.2 to 14 sec) (G-I = 1, G-1I = 2, G-Ill = 1) and two ofbradycardia of less than 50 beats per minute (in Group Ili) followed the reinjection of succinylcholine. In fact, succinylcholine reinjection is a dangerous procedure and neither CANADIAN ANAESTHETISTS' SOCIETY JOURNAL intravenous d-tubocurarine nor intravenous diazepam provide adequate protection.
In view of the literature on this particular side effect of succinylcholine reinjection, we feel that there is at present no protection against this potentially harmful side-effect, except for the possible protective effect of glycopyrrolate. 
